You searched for "regenerative"
New helpline to offer support to thousands of Scots with sight loss
The new telephone service from Sight Scotland, Scotland’s largest sight loss charity, offers someone for people with sight loss and their families to turn to for information, advice and support.RNIB focusing on supporting patients to ‘wait well’ at point of diagnosis this National Eye Health Week
To coincide with National Eye Health Week (18-24 September), the Royal National Institute of Blind People (RNIB) has launched a free guide bringing together information about services, tips for questions to ask when attending hospital appointments, and links to emotional support to help while you wait to find out more.Quantum technology first in eye disease detection
Scientists are working on a new device that could lead to a reduction in the number of people who go blind from age-related macular degeneration (AMD).Blind Football Fan ‘Scores’ Support
A Ross County supporter has praised the club and leading sight loss charity, RNIB Scotland, for helping him to keep attending games.Warfarin Induced Suprachoroidal Haemorrhage Presenting as Acute Angle Closure Glaucoma
Spontaneous suprachoroidal haemorrhage is a rare but recognised entity. Anticoagulant therapy is a well known risk factor. We describe a case of warfarin induced suprachoroidal haemorrhage presenting as acute angle closure glaucoma in a patient with raised International Normalised Ratio...
Efficacy and safety of intravitreal faricimab in nAMD, DME and RVO
This paper is an analysis of data extracted from 13 eligible studies in the context of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), collected from systematic literature search of MEDLINE, Embase, and Cochrane...Clinical trial investigates ‘Light Touch’ approach to wet AMD treatment
A clinical trial led by NIHR Moorfields Clinical Research Facility will explore a new ‘light-touch’ treatment approach for patients with neovascular age-related macular degeneration (wet AMD) that could result in fewer injections and reduced number of clinic visits. Funded by...
IVT Aflibercept 2mg in nAMD: XTEND at 3 years
This study investigated the long-term, effectiveness and safety of IVT-AFL 2mg for neovascular age-related macular degeneration (nAMD). XTEND was a multicentre, observational, prospective study, which was conducted across 127 centres across 17 countries with a follow-up period of 36 months....Code-Free Deep Learning: a step into the future of ophthalmology
A new focus has arisen within the research domain of artificial intelligence (AI) in healthcare called code-free deep learning (CFDL), and recent research demonstrates that ophthalmology is becoming one of the leading specialties in this field. Artificial intelligence (AI) is...
The effect of everolimus on retinal pigment epithelium and proliferative vitreo-retinopathy
The principal cells involved in proliferative vitreo-retinopathy (PVR) are retinal pigment epithelial cells (RPE). Everolimus is a drug used in renal cell carcinoma which targets and inhibits a key regulatory protein in cancer (mTOR). In this study, the authors investigated...
Beta blocker treatment for capillary haemangioma
This randomised controlled trial of 25 patients aimed to evaluate the safety and efficacy of combined oral and topical beta blockers for the treatment of superficial periocular infantile capillary haemangioma at the early proliferative stage. Group 1 (n=13) were given...
